BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 36788082)

  • 21. Immunohistochemical study of calretinin in normal skin and cutaneous adnexal proliferations.
    González-Guerra E; Kutzner H; Rutten A; Requena L
    Am J Dermatopathol; 2012 Jul; 34(5):491-505. PubMed ID: 22343111
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nuclear factor XIIIa staining (clone AC-1A1 mouse monoclonal) is a sensitive and specific marker to discriminate sebaceous proliferations from other cutaneous clear cell neoplasms.
    Uhlenhake EE; Clark LN; Smoller BR; Shalin SC; Gardner JM
    J Cutan Pathol; 2016 Aug; 43(8):649-56. PubMed ID: 27153339
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Topics in histopathology of sweat gland and sebaceous neoplasms.
    Ansai SI
    J Dermatol; 2017 Mar; 44(3):315-326. PubMed ID: 28256768
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An immunohistochemical study of the apocrine type of cutaneous mixed tumors with special reference to their follicular and sebaceous differentiation.
    Yamamoto O; Yasuda H
    J Cutan Pathol; 1999 May; 26(5):232-41. PubMed ID: 10408348
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nuclear factor XIIIa staining (clone AC-1A1 mouse monoclonal) is a highly sensitive marker of sebaceous differentiation in normal and neoplastic sebocytes.
    Clark LN; Elwood HR; Uhlenhake EE; Smoller BR; Shalin SC; Gardner JM
    J Cutan Pathol; 2016 Aug; 43(8):657-62. PubMed ID: 27153463
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adnexal skin tumors in Zaria, Nigeria.
    Samaila MO
    Ann Afr Med; 2008 Mar; 7(1):6-10. PubMed ID: 18702242
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular pathology of skin adnexal tumours.
    Plotzke JM; Adams DJ; Harms PW
    Histopathology; 2022 Jan; 80(1):166-183. PubMed ID: 34197659
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adnexal and Sebaceous Carcinomas.
    Seger EW; Neill BC; Tolkachjov SN
    Dermatol Clin; 2023 Jan; 41(1):117-132. PubMed ID: 36410972
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation and comparison of staining patterns of factor XIIIa (AC-1A1), adipophilin and GATA3 in sebaceous neoplasia.
    Tjarks BJ; Pownell BR; Evans C; Thompson PA; Kerkvliet AM; Koch MRD; Jassim AD
    J Cutan Pathol; 2018 Jan; 45(1):1-7. PubMed ID: 28873247
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Perilipin and adipophilin expression in sebaceous carcinoma and mimics.
    Boussahmain C; Mochel MC; Hoang MP
    Hum Pathol; 2013 Sep; 44(9):1811-6. PubMed ID: 23642680
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumor of the follicular infundibulum with sebaceous differentiation.
    Mahalingam M; Bhawan J; Finn R; Stefanato CM
    J Cutan Pathol; 2001 Jul; 28(6):314-7. PubMed ID: 11401679
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nectin-4 expression in a subset of cutaneous adnexal carcinomas: A potential target for therapy with enfortumab vedotin.
    Cho WC; Saade R; Nagarajan P; Aung PP; Milton DR; Marques-Piubelli ML; Hudgens C; Ledesma D; Nelson K; Ivan D; Zhang M; Torres-Cabala CA; Campbell M; Alhalabi O; Prieto VG; Wistuba II; Esmaeli B; Curry JL
    J Cutan Pathol; 2024 May; 51(5):360-367. PubMed ID: 38200650
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sex steroid hormone receptors in human skin appendage and its neoplasms.
    Kariya Y; Moriya T; Suzuki T; Chiba M; Ishida K; Takeyama J; Endoh M; Watanabe M; Sasano H
    Endocr J; 2005 Jun; 52(3):317-25. PubMed ID: 16006726
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Perforin expression in eyelid sebaceous carcinomas: a useful and specific immunomarker for the differential diagnosis of eyelid carcinomas.
    Mittal R; Araujo I; Czanner G; Coupland SE
    Acta Ophthalmol; 2016 Aug; 94(5):e325-30. PubMed ID: 26843360
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Microcystic adnexal carcinoma with sebaceous differentiation: Three cases.
    Fernandez-Flores A; Llamas-Velasco M; Saus C; Patel A; Rutten A
    J Cutan Pathol; 2018 Apr; 45(4):290-295. PubMed ID: 29352496
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunolabeling pattern of cytokeratin 19 expression may distinguish sebaceous tumors from basal cell carcinomas.
    Heyl J; Mehregan D
    J Cutan Pathol; 2008 Jan; 35(1):40-5. PubMed ID: 18095993
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Practical immunohistochemistry of epithelial skin tumor.
    Alhumaidi A
    Indian J Dermatol Venereol Leprol; 2012; 78(6):698-708. PubMed ID: 23075638
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Spatial analysis of p63, K5 and K7 defines two groups of progenitor cells that differentially contribute to the maintenance of normal sebaceous glands, extraocular sebaceous carcinoma and benign sebaceous tumors.
    Boecker W; Reusch M; Mielke V; Reusch U; Loening T; Tiemann M; Buchwalow I
    J Dermatol; 2019 Mar; 46(3):249-258. PubMed ID: 30663115
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ocular Adnexal Adenomatoid Sebaceous Gland Hyperplasia: A Clinical and Immunopathologic Analysis in Relation to the Muir-Torre Syndrome.
    Jakobiec FA; Cortes Barrantes P; Milman T; Lee NG; Fay A
    Ophthalmic Plast Reconstr Surg; 2020; 36(1):e6-e12. PubMed ID: 31593035
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Potentially actionable FGFR2 high-level amplification in thymic sebaceous carcinoma.
    Porubsky S; Jessup P; Kee D; Sharma R; Ochi A; Xu H; Froelich JJ; Nott L; Scott C; Awad R; Moldovan C; Hardikar AA; Bohnenberger H; Küffer S; Ströbel P; Marx A
    Virchows Arch; 2020 Feb; 476(2):323-327. PubMed ID: 31401665
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.